Top Regulatory News Stories – Week Ending October 6, 2017

After a very busy month of approvals and rejections in September, this week has been relatively quiet. Here are the top regulatory news stories for pharma and biotech this week: According to the latest FY 2017 activities report, the US FDA has approved more abbreviated new drug application (ANDA) in 2017 than any other year: […]